呼吸道合胞病毒：迫切需要创新的预防策略。
Respiratory Syncytial Virus: The Urgent Need for Innovative Preventive Strategies.
作者信息
Virgili Fabrizio, Midulla Fabio, de Benedictis Fernando Maria
机构信息
Department of Maternal Infantile and Urological Sciences, Sapienza University of Rome, 00185 Rome, Italy.
Salesi Children's Hospital Foundation, 60123 Ancona, Italy.
出版信息
Pediatr Rep. 2024 Aug 8;16(3):678-683. doi: 10.3390/pediatric16030057.
Abstract
Respiratory Syncytial Virus (RSV) is a medium-sized enveloped Pneumovirus belonging to the Paramyxoviridae family [...].
摘要
呼吸道合胞病毒（RSV）是一种中等大小的包膜肺病毒，属于副粘病毒科[...]。
相似文献
1
Respiratory Syncytial Virus: The Urgent Need for Innovative Preventive Strategies.呼吸道合胞病毒：迫切需要创新的预防策略。
Pediatr Rep. 2024 Aug 8;16(3):678-683. doi: 10.3390/pediatric16030057.
2
Highly Potent Host-Specific Small-Molecule Inhibitor of Paramyxovirus and Pneumovirus Replication with High Resistance Barrier.高效能、宿主特异性的小分子量病毒抑制剂，对副黏病毒和肺炎病毒具有高效抵抗屏障的复制能力。
mBio. 2021 Dec 21;12(6):e0262121. doi: 10.1128/mBio.02621-21. Epub 2021 Nov 2.
3
Immunization strategies for the prevention of pneumovirus infections.预防肺病毒感染的免疫策略。
Expert Rev Vaccines. 2007 Apr;6(2):169-82. doi: 10.1586/14760584.6.2.169.
4
The Changing Landscape of Respiratory Syncytial Virus Infections.呼吸道合胞病毒感染的变化态势
Pathogens. 2023 Sep 26;12(10):1196. doi: 10.3390/pathogens12101196.
5
Inflammatory responses to respiratory syncytial virus (RSV) infection and the development of immunomodulatory pharmacotherapeutics.呼吸道合胞病毒 (RSV) 感染的炎症反应和免疫调节药物的研发。
Curr Med Chem. 2012;19(10):1424-31. doi: 10.2174/092986712799828346.
6
Respiratory syncytial virus infection in older adults: an under-recognized problem.老年人呼吸道合胞病毒感染：一个未得到充分认识的问题。
Drugs Aging. 2015 Apr;32(4):261-9. doi: 10.1007/s40266-015-0258-9.
7
Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.深入了解和控制呼吸道合胞病毒方面的进展：这么多年过去了，仍然让人感到疯狂。
Virus Res. 2011 Dec;162(1-2):80-99. doi: 10.1016/j.virusres.2011.09.020. Epub 2011 Sep 22.
8
Epidemiology, molecular epidemiology and evolution of bovine respiratory syncytial virus.牛呼吸道合胞体病毒的流行病学、分子流行病学和进化。
Viruses. 2012 Nov 30;4(12):3452-67. doi: 10.3390/v4123452.
9
Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccine.融合前稳定的呼吸道合胞病毒 F 亚单位疫苗诱导肺炎病毒特异性 B 细胞应答。
Sci Transl Med. 2022 Jun 22;14(650):eabo5032. doi: 10.1126/scitranslmed.abo5032.
10
A gammaherpesvirus licenses CD8 T cells to protect the host from pneumovirus-induced immunopathologies.γ疱疹病毒使 CD8 T 细胞获得许可，以保护宿主免受肺炎病毒引起的免疫病理损伤。
Mucosal Immunol. 2020 Sep;13(5):799-813. doi: 10.1038/s41385-020-0293-7. Epub 2020 May 18.
本文引用的文献
1
Monoclonal antibody therapies in respiratory syncytial virus prophylaxis-An umbrella review.呼吸道合胞病毒预防中的单克隆抗体疗法——伞式综述。
Pediatr Pulmonol. 2024 Oct;59(10):2374-2380. doi: 10.1002/ppul.27041. Epub 2024 May 15.
2
A Historical Perspective on Respiratory Syncytial Virus Prevention: A Journey Spanning Over Half a Century From the Setback of an Inactive Vaccine Candidate to the Success of Passive Immunization Strategy.呼吸道合胞病毒预防的历史视角：从无效疫苗候选物的挫折到被动免疫策略的成功，跨越半个多世纪的历程。
J Pediatric Infect Dis Soc. 2024 Jul 12;13(Supplement_2):S103-S109. doi: 10.1093/jpids/piae027.
3
RSV Prefusion F Protein-Based Maternal Vaccine - Preterm Birth and Other Outcomes.RSV 融合前 F 蛋白为基础的母体疫苗-早产和其他结局。
N Engl J Med. 2024 Mar 14;390(11):1009-1021. doi: 10.1056/NEJMoa2305478.
4
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.2023 年 10 月至 2024 年 2 月，新疫苗监测网络对婴儿进入首个呼吸道合胞病毒季节时，尼赛珠单抗预防呼吸道合胞病毒相关住院的早期效果评估。
MMWR Morb Mortal Wkly Rep. 2024 Mar 7;73(9):209-214. doi: 10.15585/mmwr.mm7309a4.
5
Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024.2023 年 10 月至 2024 年 1 月，西班牙对婴儿呼吸道合胞病毒下呼吸道感染住院进行 nirsevimab 免疫预防的早期效果评估。
Euro Surveill. 2024 Feb;29(6). doi: 10.2807/1560-7917.ES.2024.29.6.2400046.
6
Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants.尼赛珠单抗预防婴儿呼吸道合胞病毒住院治疗。
N Engl J Med. 2023 Dec 28;389(26):2425-2435. doi: 10.1056/NEJMoa2309189.
7
New Insights on Respiratory Syncytial Virus Prevention.呼吸道合胞病毒预防的新见解
Vaccines (Basel). 2023 Nov 30;11(12):1797. doi: 10.3390/vaccines11121797.
8
Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.老年人使用呼吸道合胞病毒疫苗：免疫实践咨询委员会的建议-美国，2023 年。
Am J Transplant. 2023 Oct;23(10):1631-1640. doi: 10.1016/j.ajt.2023.09.003.
9
Evaluation of the Live-Attenuated Intranasal Respiratory Syncytial Virus (RSV) Vaccine RSV/6120/ΔNS2/1030s in RSV-Seronegative Young Children.评价活减毒鼻内呼吸道合胞病毒（RSV）疫苗 RSV/6120/ΔNS2/1030s 在 RSV 血清阴性的婴幼儿中的效果。
J Infect Dis. 2024 Feb 14;229(2):346-354. doi: 10.1093/infdis/jiad281.
10
Pediatric Respiratory Syncytial Virus Diagnostic Testing Performance: A Systematic Review and Meta-analysis.儿科呼吸道合胞病毒诊断测试性能：系统评价和荟萃分析。
J Infect Dis. 2023 Nov 28;228(11):1516-1527. doi: 10.1093/infdis/jiad185.
Zotero 插件